Open Access iconOpen Access

REVIEW

crossmark

Cellular and molecular insights into microbiota-mitochondria interplay, therapeutic biomarkers and interventional approaches in COVID-19: A review

VIBHAV VARSHNEY1,*, PRASHANT SINGH KUSHWAH2, NEETU AGRAWAL1, AHSAS GOYAL1,*, GOVIND SINGH2

1 Institute of Pharmaceutical Research, GLA University, Mathura, India
2 Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India

* Corresponding Authors: VIBHAV VARSHNEY. Email: email; AHSAS GOYAL. Email: email

BIOCELL 2023, 47(10), 2141-2149. https://doi.org/10.32604/biocell.2023.030853

Abstract

The persistent global pandemic, COVID-19, stems from the pathogenic influence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), yielding an unprecedented worldwide crisis. With reference to a WHO report, the count of COVID-19 cases had exceeded 754 million by February 03, 2023. Intriguingly, emerging research has spotlighted the intricate interplay of gut microbiota and mitochondrial entities, acting as potent immunomodulatory factors at the cellular and molecular levels. This interconnection operates through a series of dynamic mechanisms. SARS-CoV-2 infection perturbs the delicate equilibrium of gut microbiota, leading to dysbiosis—a signature biomarker. This imbalance is intrinsically linked to exacerbated COVID-19 progression. Mechanistically, this microbial dysbiosis triggers aberrant immune responses, marked by cytokine storms, while also inducing mitochondrial dysfunction. Mitochondrial activities crucial to energy production and immunoregulation are compromised. This dual perturbation of microbiota and mitochondria contributes to disease severity. This review provides a comprehensive overview of these interconnected mechanisms, illuminating how microbiota-mitochondria interplay serves as both a diagnostic biomarker and a promising therapeutic target in the realm of COVID-19.

Keywords


Cite This Article

APA Style
VARSHNEY, V., KUSHWAH, P.S., AGRAWAL, N., GOYAL, A., SINGH, G. (2023). Cellular and molecular insights into microbiota-mitochondria interplay, therapeutic biomarkers and interventional approaches in COVID-19: A review. BIOCELL, 47(10), 2141-2149. https://doi.org/10.32604/biocell.2023.030853
Vancouver Style
VARSHNEY V, KUSHWAH PS, AGRAWAL N, GOYAL A, SINGH G. Cellular and molecular insights into microbiota-mitochondria interplay, therapeutic biomarkers and interventional approaches in COVID-19: A review. BIOCELL . 2023;47(10):2141-2149 https://doi.org/10.32604/biocell.2023.030853
IEEE Style
V. VARSHNEY, P.S. KUSHWAH, N. AGRAWAL, A. GOYAL, and G. SINGH "Cellular and molecular insights into microbiota-mitochondria interplay, therapeutic biomarkers and interventional approaches in COVID-19: A review," BIOCELL , vol. 47, no. 10, pp. 2141-2149. 2023. https://doi.org/10.32604/biocell.2023.030853



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 391

    View

  • 272

    Download

  • 0

    Like

Share Link